Skip to main content
CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.410
-0.250 (-6.83%)
Dec 20, 2024, 4:00 PM EST - Market closed

CollPlant Biotechnologies Revenue

CollPlant Biotechnologies had revenue of $4.00K in the quarter ending September 30, 2024, a decrease of -90.70%. This brings the company's revenue in the last twelve months to $650.00K, down -93.94% year-over-year. In the year 2023, CollPlant Biotechnologies had annual revenue of $10.96M with 3,565.22% growth.

Revenue (ttm)
$650.00K
Revenue Growth
-93.94%
P/S Ratio
60.09
Revenue / Employee
$8,667
Employees
75
Market Cap
39.06M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.96M10.66M3,565.22%
Dec 31, 2022299.00K-15.34M-98.09%
Dec 31, 202115.64M9.50M154.86%
Dec 31, 20206.14M3.82M164.75%
Dec 31, 20192.32M-2.70M-53.77%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rapid Micro Biosystems 26.17M
ImmuCell 23.84M
SCYNEXIS 8.57M
OneMedNet 957.65K
Lexaria Bioscience 464.28K
Cardio Diagnostics Holdings 35.69K
Revenue Rankings

CLGN News

More News